MRP Capital Investments’s Medline Inc MDLN Stock Holding History

MRP Capital Investments’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300	Closed	-$12.6K	–	230
2025 Q4	$12.6K	Buy	+300	New	+$12.7K	0.01%	164

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

MRP Capital Investments's MDLN Position: Q1 2026 in Review

MRP Capital Investments sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 300 shares — an estimated $12.6K sold.

MRP Capital Investments first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $12.6K in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

MRP Capital Investments reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
MRP Capital Investments sold 300 Medline Inc shares in Q1 2026, an estimated $12.6K.
MRP Capital Investments first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
MRP Capital Investments's Medline Inc position peaked at $12.6K in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.